查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2067491

糞便抗原檢測市場規模、佔有率和趨勢分析報告：按檢測類型、技術、應用、最終用途、地區和細分市場預測（2026-2033 年）

Stool Antigen Testing Market Size, Share & Trends Analysis Report By Test Type, By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

糞便抗原檢測市場概覽

全球糞便抗原檢測市場預計到 2025 年將達到 6.7911 億美元，到 2026 年將成長到 7.6217 億美元，到 2033 年將擴大到 13.3423 億美元，2026 年至 2033 年的年複合成長率（CAGR）。

預計到 2025 年，北美糞便抗原檢測市場將佔據全球市場最大的佔有率，達到 39.76%。這是由於幽門螺旋桿菌感染和腹瀉等胃腸道感染疾病的日益普遍，而這些疾病需要準確和早期的診斷。

此外，ELISA 和快速免疫檢測等檢測技術的進步也推動了市場成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 產業分析工具

第4章：依測試類型進行業務分析

  • 糞便抗原檢測市場：按檢測類型分類的波動分析
  • 細菌抗原檢測
    • 細菌抗原檢測市場，2021-2033年
  • 病毒抗原檢測
    • 病毒抗原檢測市場，2021-2033年
  • 寄生蟲抗原檢測
    • 寄生蟲抗原檢測市場，2021-2033年
  • 多重/複合糞便檢驗
    • 2021-2033年多重/複合糞便檢驗市場

第5章：依技術進行業務分析

  • 糞便抗原檢測市場：基於技術的波動分析
  • 酵素免疫分析法（ELISA）
    • 2021-2033年酵素免疫分析法（ELISA）市場
  • 側向流動免疫檢測（快速檢測）
    • 側向流動免疫檢測（快速檢測）市場，2021-2033年
  • 層析法
    • 層析法市場，2021-2033年
  • 螢光免疫分析
    • 螢光免疫分析市場，2021-2033年

第6章 應用業務分析

  • 糞便抗原檢測市場：按應用領域分類的波動分析
  • 胃腸道感染疾病的診斷
    • 2021-2033年消化道感染疾病診斷市場
  • 幽門螺旋桿菌檢測
    • 幽門螺旋桿菌檢測市場，2021-2033年
  • 腹瀉疾病的診斷
    • 腹瀉疾病診斷市場，2021-2033年
  • 寄生蟲傳染病篩檢
    • 寄生蟲傳染病篩檢市場，2021-2033年
  • 醫院感染監測
    • 醫院感染監測市場，2021-2033年

第7章 依最終用途進行業務分析

  • 醫院和診所
    • 醫院和診所市場，2021-2033年
  • 診斷實驗室
    • 診斷實驗室市場，2021-2033年
  • 家庭和就地檢驗環境
    • 2021-2033年家庭與就地檢驗市場
  • 學術研究機構
    • 學術與研究機構市場，2021-2033年
  • 門診部
    • 2021-2033年門診診所市場

第8章 區域業務分析

  • 糞便抗原檢測市場佔有率：按地區分類，2025 年和 2033 年
  • 北美洲
    • SWOT分析
    • 2021-2033年北美糞便抗原檢測市場
    • 美國
    • 墨西哥
    • 加拿大
  • 歐洲
    • SWOT分析
    • 2021-2033年歐洲糞便抗原檢測市場
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 2021-2033年亞太地區糞便抗原檢測市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • SWOT分析
    • 2021-2033年拉丁美洲糞便抗原檢測市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • SWOT分析
    • 2021-2033年中東及非洲糞便抗原檢測市場
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 科威特

第9章 競爭情勢

  • 公司分類
  • 策略規劃
  • 2022年企業市場占有率分析
  • 公司簡介列表
    • Abbott
    • BIOMERIEUX
    • Thermo Fisher Scientific Inc
    • F. Hoffmann-La Roche Ltd.
    • Meridian Biosience, Inc.
    • Danaher Corporation（Beckman Coulter）
    • BD
    • TECHLAB, Inc.
    • QuidelOrtho Corporation
    • DiaSorin SpA
    • Trinity BIoTech
    • CERTEST BIOTEC
Product Code: GVR-4-68040-926-7

Stool Antigen Testing Market Summary

The global stool antigen testing market size was valued at USD 679.11 million in 2025 and is projected to grow from USD 762.17 million in 2026 to USD 1334.23 million by 2033, at a CAGR of 8.33% from 2026 to 2033. The North America stool antigen testing market held the largest share of 39.76% of the global market in 2025, due to the rising prevalence of gastrointestinal infections such as H. pylori and diarrheal diseases, which require accurate and early diagnosis.

Furthermore, growth is also supported by improvements in testing technologies such as ELISA and rapid immunoassays.

Global Stool Antigen Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global stool antigen testing market report based on test type, technology, application, end use, and region.

  • Test Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Bacterial Antigen test
  • Viral Antigen Tests
  • Parasitic Antigen Tests
  • Multiplex/Combination Stool Antigen Panels
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Lateral Flow Immunoassays (Rapid Tests)
  • Immunochromatography Assays
  • Fluorescent Immunoassays
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Gastrointestinal Infection Diagnosis
  • Helicobacter pylori Detection
  • Diarrheal Disease Diagnosis
  • Parasitic Infection Screening
  • Hospital-Acquired Infection Monitoring
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Academic & Research Institutes
  • Ambulatory Care Centers
  • Home/point-of-care testing settings
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Test Type Segment
      • 1.1.1.2. Application Segment
      • 1.1.1.3. Technology Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
    • 1.3.1. Objectives
    • 1.3.2. Objective - 1
    • 1.3.3. Objective - 2
    • 1.3.4. Objective - 3
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information or Data Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Test Type & Technology Snapshot
  • 2.3. Application & End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of gastrointestinal infections and digestive disorders Advancements in imaging techniques and increasing affordability of diagnostics
      • 3.2.1.2. Growing preference for non-invasive diagnostic methods
      • 3.2.1.3. Advancements in diagnostic technologies and point-of-care testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Limited accuracy and the risk of false results
      • 3.2.2.2. Lack of awareness and limited access in developing regions
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Test Type Business Analysis

  • 4.1. Stool Antigen Testing Market: Test Type Movement Analysis
  • 4.2. Bacterial Antigen Test
    • 4.2.1. Bacterial Antigen Test Market, 2021 - 2033 (USD Million)
  • 4.3. Viral Antigen Test
    • 4.3.1. Viral Antigen Test Market, 2021 - 2033 (USD Million)
  • 4.4. Parasitic Antigen Test
    • 4.4.1. Parasitic Antigen Test Market, 2021 - 2033 (USD Million)
  • 4.5. Multiplex/Combination Stool Test
    • 4.5.1. Multiplex/Combination Stool Test Market, 2021 - 2033 (USD Million)

Chapter 5. Technology Business Analysis

  • 5.1. Stool Antigen Testing Market: Technology Movement Analysis
  • 5.2. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 5.2.1. Enzyme-Linked Immunosorbent Assay (ELISA) Market, 2021 - 2033 (USD Million)
  • 5.3. Lateral Flow Immunoassays (Rapid Tests)
    • 5.3.1. Lateral Flow Immunoassays (Rapid Tests) Market, 2021 - 2033 (USD Million)
  • 5.4. Immunochromatography Assays
    • 5.4.1. Immunochromatography Assays Market, 2021 - 2033 (USD Million)
  • 5.5. Fluorescent Immunoassays
    • 5.5.1. Fluorescent Immunoassays Market, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Stool Antigen Testing Market: Application Movement Analysis
  • 6.2. Gastrointestinal Infection Diagnosis
    • 6.2.1. Gastrointestinal Infection Diagnosis Market, 2021 - 2033 (USD Million)
  • 6.3. Helicobacter pylori Detection
    • 6.3.1. Helicobacter pylori Detection Market, 2021 - 2033 (USD Million)
  • 6.4. Diarrheal Disease Diagnosis
    • 6.4.1. Diarrheal Disease Diagnosis Market, 2021 - 2033 (USD Million)
  • 6.5. Parasitic Infection Screening
    • 6.5.1. Parasitic Infection Screening Market, 2021 - 2033 (USD Million)
  • 6.6. Hospital-Acquired Infection Monitoring
    • 6.6.1. Hospital-Acquired Infection Monitoring Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Hospitals & Clinics
    • 7.1.1. Hospitals & Clinics Market, 2021 - 2033 (USD Million)
  • 7.2. Diagnostic Laboratories
    • 7.2.1. Diagnostic Laboratories Market, 2021 - 2033 (USD Million)
  • 7.3. Home/point-of-care testing settings
    • 7.3.1. Home/point-of-care testing settings Market, 2021 - 2033 (USD Million)
  • 7.4. Academic & Research Institutes
    • 7.4.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 7.5. Ambulatory Care Centers
    • 7.5.1. Ambulatory Care Centers Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Stool Antigen Testing Market Share By Region, 2025 & 2033
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. U.S. Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Mexico Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.2.5. Canada
      • 8.2.5.1. Key Country Dynamics
      • 8.2.5.2. Target Disease Prevalence
      • 8.2.5.3. Competitive Scenario
      • 8.2.5.4. Regulatory Framework
      • 8.2.5.5. Canada Stool Antigen Testing Market, 2021 - 2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. UK Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Germany Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.3.5. Spain
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Spain Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.3.6. France
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. France Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.3.7. Italy
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Italy Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Denmark Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Sweden Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Target Disease Prevalence
      • 8.3.10.3. Competitive Scenario
      • 8.3.10.4. Regulatory Framework
      • 8.3.10.5. Norway Stool Antigen Testing Market, 2021 - 2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Japan Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. China Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. India Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. South Korea Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.4.7. Australia
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Australia Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.4.8. Thailand
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. Thailand Stool Antigen Testing Market, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Brazil Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Argentina Stool Antigen Testing Market, 2021 - 2033 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. South Africa Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. UAE Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.6.5. Saudi Arabia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Saudi Arabia Stool Antigen Testing Market, 2021 - 2033 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Regulatory Framework
      • 8.6.6.5. Kuwait Stool Antigen Testing Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2022
  • 9.4. Company Profiles/Listing
    • 9.4.1. Abbott
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.1.3. Technology Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. BIOMERIEUX
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.2.3. Technology Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Thermo Fisher Scientific Inc
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.3.3. Technology Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. F. Hoffmann- La Roche Ltd.
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.4.3. Technology Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Meridian Biosience, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.5.3. Technology Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Danaher Corporation (Beckman Coulter)
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.6.3. Technology Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. BD
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.7.3. Technology Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. TECHLAB, Inc.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.8.3. Technology Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. QuidelOrtho Corporation
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.9.3. Technology Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. DiaSorin S.p.A.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.10.3. Technology Benchmarking
      • 9.4.10.4. Strategic Initiatives
    • 9.4.11. Trinity Biotech
      • 9.4.11.1. Overview
      • 9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.11.3. Technology Benchmarking
      • 9.4.11.4. Strategic Initiatives
    • 9.4.12. CERTEST BIOTEC
      • 9.4.12.1. Overview
      • 9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.4.12.3. Technology Benchmarking
      • 9.4.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global stool antigen testing market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 4 Global stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 5 Global stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 6 Global stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 7 North America stool antigen testing market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 9 North America stool antigen testing market by test type, 2021 - 2033 (USD Million)
  • Table 10 North America stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 11 North America stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 12 U.S. stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 13 U.S. stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 14 U.S. stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 15 U.S. stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Canada stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 17 Canada stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 18 Canada stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 19 Canada stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Mexico stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 21 Mexico stool l antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 22 Mexico stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 23 Mexico stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Europe stool antigen testing market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 26 Europe stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 27 Europe stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 28 Europe stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 29 UK Stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 30 UK Stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 31 UK Stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 32 UK Stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 33 Germany stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 34 Germany stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 35 Germany stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 36 Germany stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 37 France stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 38 France stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 39 France stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 40 France stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Italy stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 42 Italy stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 43 Italy stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 44 Italy stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Spain stool l antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 46 Spain stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 47 Spain stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 48 Spain stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Denmark stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Denmark stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 51 Denmark stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 52 Denmark stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Sweden stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 54 Sweden stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 55 Sweden stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 56 Sweden stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Norway stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 58 Norway stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 59 Norway stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 60 Norway stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific stool antigen testing market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Japan stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 67 Japan stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 68 Japan stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 69 Japan stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 70 China stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 71 China stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 72 China stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 73 China stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 74 India stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 75 India stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 76 India stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 77 India stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 78 Australia Stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 79 Australia stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 80 Australia stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 81 Australia stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 82 South Korea stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 83 South Korea stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 84 South Korea stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 85 South Korea stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Thailand stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 87 Thailand stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 88 Thailand stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 89 Thailand stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 90 Latin America Stool antigen testing market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America Stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 92 Latin America Stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 93 Latin America stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 94 Latin America stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 95 Brazil Stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 96 Brazil Stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 97 Brazil Stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 98 Brazil Stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 99 Argentina stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 100 Argentina stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 101 Argentina stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 102 Argentina stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 103 MEA stool antigen testing market, by country, 2021 - 2033 (USD Million)
  • Table 104 MEA stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 105 MEA stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 106 MEA stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 107 MEA stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 108 South Africa stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 109 South Africa stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 110 South Africa stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 111 South Africa stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 116 UAE stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 117 UAE stool antigen testing market, by test type, 2021 - 2033 (USD Million)
  • Table 118 UAE stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 119 UAE stool antigen testing market, by end use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait stool antigen testing market, by technology, 2021 - 2033 (USD Million)
  • Table 121 Kuwait stool l antigen testing market, by test type, 2021 - 2033 (Stool)
  • Table 122 Kuwait stool antigen testing market, by application, 2021 - 2033 (USD Million)
  • Table 123 Kuwait stool antigen testing market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Stool antigen testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Test type and technology snapshot
  • Fig. 11 Application and end use segment snapshot
  • Fig. 12 Competitive landscape snapshot
  • Fig. 13 Market trends & outlook
  • Fig. 14 Porter's five force analysis
  • Fig. 15 PESTEL analysis
  • Fig. 16 Stool Antigen Testing Market: Test type outlook and key takeaways
  • Fig. 17 Stool Antigen Testing Market: Test type movement analysis
  • Fig. 18 Bacterial antigen test market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Viral antigen tests market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Parasitic antigen tests market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Multiplex/combination stool antigen panels market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Stool Antigen Testing Market: Technology outlook and key takeaways
  • Fig. 23 Stool Antigen Testing Market: Technology movement analysis
  • Fig. 24 Enzyme-Linked Immunosorbent Assay (ELISA) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Lateral Flow Immunoassays (Rapid Tests) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Fluorescent Immunoassays market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Stool Antigen Testing Market: Application outlook and key takeaways
  • Fig. 28 Stool Antigen Testing Market: Application movement analysis
  • Fig. 29 Gastrointestinal infection diagnosis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Helicobacter pylori detection market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Diarrheal disease diagnosis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Parasitic infection screening market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Hospital-acquired infection monitoring market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Stool Antigen Testing Market: End Use outlook and key takeaways
  • Fig. 35 Stool Antigen Testing Market: End Use movement analysis
  • Fig. 36 Hospitals & clinics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Diagnostic laboratories market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Academic & research institutes market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Ambulatory care centers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Home/point-of-care Testing Settings
  • Fig. 41 Stool Antigen Testing Market revenue, by region, 2023 & 2033 (USD Million)
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 North America Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 U.S. Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Canada Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Mexico Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Europe Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 UK Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Germany Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 France Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Spain Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Denmark Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Sweden Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Norway Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Rest of Europe Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 69 Asia Pacific Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Japan Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 China Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 India Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Australia Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Thailand Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 South Korea Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 82 Rest of Asia Pacific Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 83 Latin America Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 84 Fig127 Key country dynamics
  • Fig. 85 Brazil Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Argentina Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 88 Rest of Latin America Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 89 MEA Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 South Africa Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 Saudi Arabia Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 UAE Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Kuwait Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 98 Rest of MEA Stool Antigen Testing Market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 99 Key company categorization
  • Fig. 100 Company market share analysis, 2025
  • Fig. 101 Strategic framework